Patient: A 51 year old female patient presented to the ER with gradually worsening shortness of breath.

Initial Examination: She had a history of coronary artery disease and ischemic mitral regurgitation treated with CABG and mitral valve repair three years earlier. On clinical examination a holosystolic apical murmur was noted. Her jugular veins were dilated and lower limb edema was present.

Kosmos POCUS Examination: Bedside examination with KOSMOS revealed impaired systolic function of both ventricles accompanied by severe residual ischemic mitral regurgitation and significant functional tricuspid regurgitation. Intravenous diuresis was promptly initiated resulting in improvement of her symptoms.

PLAX view showing dilated left ventricle with segmental wall motion abnormalities and impaired systolic function. A prosthetic mitral annuloplasty ring is seen and there is restriction of the posterior mitral valve leaflet. A left pleural effusion is also visible.

PLAX view with color showing severe residual mitral regurgitation

RV inflow view

RV inflow view with color showing significant tricuspid regurgitation

CW TR signal from RV inflow view

PSAX view at the level of the papillary muscles demonstrating severely impaired LV systolic function and the presence of segmental wall motion abnormalities

A4C view showing dilated LV with segmental wall motion abnormalities and impaired LV systolic function. The RV is hyperdynamic with overall mildly impaired RV systolic function. There is lack of coaptation of the TV leaflets. Bi-atrial enlargement is also evident.

A4C view with color on the TV showing severe TR

CW TR signal from the A4C view

Assessment of TAPSE with the use of M-mode from the A4C view

A4C view with color on the repaired mitral valve showing severe residual MR

CW MR signal from the A4C view

Subcostal view showing dilated IVC with minimal respiratory variation

PW Doppler in the hepatic veins demonstrating systolic flow reversal suggestive of severe TR

  • Turn Your POCUS Purchase into a Major 2025 Tax Deduction

    Turn Your POCUS Purchase into a Major 2025 Tax Deduction

    Turn Your Ultrasound Investment into a Major Tax Deduction in 2025 Leveraging Section 179 and Bonus Depreciation to Lower Your Tax Bill* For many private practice owners, the cost of advanced equipment like point-of-care ultrasound…

    Read More

  • Peritonsillar Abscess: The Clinical Utility of Ultrasound

    Peritonsillar Abscess: The Clinical Utility of Ultrasound

    Peritonsillar Abscess: The Clinical Utility of Ultrasound For any clinician, the patient with a suspected peritonsillar abscess (PTA) presents a relatively common but critical diagnostic challenge. The classic presentation of fever, severe odynophagia, trismus, and…

    Read More

  • How Much Does a Point-of-Care Ultrasound Device Cost? 

    How Much Does a Point-of-Care Ultrasound Device Cost? 

    How Much Does a Point-of-Care Ultrasound (POCUS) Device Cost?  The EchoNous Team | September 2025 Long gone are the days of point-of-care ultrasound (POCUS) being thought of as a niche tool; it’s truly become a…

    Read More

  • EchoNous Appoints Tony Titus as CEO

    EchoNous Appoints Tony Titus as CEO

    EchoNous Appoints Tony Titus as CEO We’re thrilled to announce the appointment of Tony Titus as our new Chief Executive Officer (CEO). Tony has over 20 years of senior executive experience, bringing a proven track…

    Read More